---
title: "Health and Happiness (H&H) International (OTCMKTS:BTSDF) Shares Up 1.9%  - Should You Buy?"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/283212677.md"
description: "Health and Happiness (H&H) International (OTCMKTS:BTSDF) shares rose 1.9% to $1.60, with 100 shares traded. The stock's 50-day and 200-day moving averages are $1.59 and $1.61, respectively. The company specializes in infant nutrition and maternal health products, operating in various Asia-Pacific markets. Analysts currently rate the stock as a Hold, suggesting it may not be a top buy compared to other recommended stocks."
datetime: "2026-04-18T05:45:20.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/283212677.md)
  - [en](https://longbridge.com/en/news/283212677.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/283212677.md)
---

# Health and Happiness (H&H) International (OTCMKTS:BTSDF) Shares Up 1.9%  - Should You Buy?

Health and Happiness (H&H) International Holdings Limited (OTCMKTS:BTSDF - Get Free Report) traded up 1.9% on Friday . The company traded as high as $1.60 and last traded at $1.60. 100 shares traded hands during mid-day trading, The stock had previously closed at $1.57.

## Health and Happiness (H&H) International Stock Performance

The stock has a 50-day moving average price of $1.59 and a 200-day moving average price of $1.61.

## Health and Happiness (H&H) International Company Profile

(Get Free Report)

Health and Happiness (H&H) International is a Hong Kong–based company specializing in infant nutrition and maternal & child health care products. The company’s core business revolves around the research, development, manufacturing and distribution of premium milk formulas, dietary supplements and related consumables, marketed under brands such as Biostime. Its product suite ranges from infant formulas and organic milks to probiotics and nutritional supplements designed for expectant mothers, infants and young children.

H&H operates multiple manufacturing facilities and quality-control laboratories that comply with internationally recognized standards, enabling the company to serve markets across Mainland China, Hong Kong, Macau and other Asia-Pacific regions.

## See Also

-   Five stocks we like better than Health and Happiness (H&H) International

_This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com._

## Should You Invest $1,000 in Health and Happiness (H&H) International Right Now?

Before you consider Health and Happiness (H&H) International, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Health and Happiness (H&H) International wasn't on the list.

While Health and Happiness (H&H) International currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

### Related Stocks

- [01112.HK](https://longbridge.com/en/quote/01112.HK.md)

## Related News & Research

- [H&H Delivers Strong Q1 Revenue Growth on China-Driven Nutrition Demand and Deleveraging](https://longbridge.com/en/news/283636437.md)
- [CLSA Reaffirms Their Buy Rating on Health and Happiness (H&H) International Holdings (BTSDF)](https://longbridge.com/en/news/283611622.md)
- [14:32 ETMySwaddle and Penfield Children's Center Take Milwaukee's Maternal Health Story to a National Stage](https://longbridge.com/en/news/286454071.md)
- [22:19 ETGROWNSY Debuted an Exciting New Line of Innovative Baby Care Products at ABC Kids Expo 2026](https://longbridge.com/en/news/286992206.md)
- [18:16 ETMomcozy Debuts New Maternal Care Innovations at ABC Kids Expo 2026](https://longbridge.com/en/news/286475942.md)